Cargando…
Hypo-fractionation radiotherapy normalizes tumor vasculature in non-small cell lung cancer xenografts through the p-STAT3/HIF-1 alpha signaling pathway
BACKGROUND: Hypo-fractionation radiotherapy (HFRT) was considered to be an important treatment for non-small cell lung cancer (NSCLC), but the radiobiological effects of HFRT on NSCLC remain unclear. The aim of this study was to investigate specific biological effect of HFRT on tumor angiogenesis, c...
Autores principales: | Tong, Fan, Xiong, Chun-jin, Wei, Chun-hua, Wang, Ye, Liang, Zhi-wen, Lu, Hui, Pan, Hui-jiao, Dong, Ji-hua, Zheng, Xue-feng, Wu, Gang, Dong, Xiao-rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605032/ https://www.ncbi.nlm.nih.gov/pubmed/33193827 http://dx.doi.org/10.1177/1758835920965853 |
Ejemplares similares
-
Retraction: Hypo-fractionation radiotherapy normalizes tumor vasculature in
non-small cell lung cancer xenografts through the p-STAT3/HIF-1 alpha signaling
pathway
Publicado: (2023) -
Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer
por: Narwariya, Abhinav, et al.
Publicado: (2022) -
Zebrafish functional xenograft vasculature platform identifies PF-502 as a durable vasculature normalization drug
por: Zhong, Jian, et al.
Publicado: (2023) -
Model-Supported Radiotherapy Personalization: In silico Test of Hyper- and Hypo-Fractionation Effects
por: Belfatto, Antonella, et al.
Publicado: (2018) -
Investigation of irradiated volume in linac-based brain hypo-fractionated stereotactic radiotherapy
por: Ruschin, Mark, et al.
Publicado: (2017)